King's College Hospital to Launch Facility in Dubai
|
By HospiMedica International staff writers Posted on 30 Nov 2015 |

Image: The King’s College Hospital Clinics in Abu Dhabi (Photo courtesy of King’s College Hospital).
King’s College Hospital (London, United Kingdom) has launched a new hospital and clinics to provide quality, evidence-based healthcare to the United Arab Emirates (UAE).
The multi-specialty Kings College Hospital Dubai (UAE), scheduled to open in 2018, will offer acute and general medical services in pediatrics, endocrinology, orthopedics, and obstetrics and gynecology disciplines. The project, budgeted at USD 200 million, will be fully integrated with King's College Hospital's facilities in London (United Kingdom). King's College Hospital already operates the Abu Dhabi clinic in the UAE, which was launched in 2014.
The Ashmore Group (London, United Kingdom), a specialist emerging markets firm with over twenty years' experience will act as the investment manager, while the Al Tayer Group (Dubai, UAE) and Dubai Investments (Dubai, UAE) will act as local equity partners. Dubai Investments has taken a 26.75% stake in the new venture, but the size of stake held by King’s College Hospital or by Al Tayer Group was not disclosed.
The new hospital will contain up to 100 beds, and is due to be built at Dubai Hills within Mohammed bin Rashid City. In addition, between three and four King’s College Hospital clinics will be opened on prime sites across Dubai during 2016-2017, with between 10 and 20 doctors on site, depending on location. In all, the partnership will be seeking to recruit up to 700 staff. A significant proportion of experienced clinicians from the UK will be brought over to the hospital in Dubai, and King’s College Hospital said that all staff and services will follow its London delivery model.
“The UK public and private healthcare system is considered among the top in the world. We are extremely excited to expand British healthcare internationally, particularly within the UAE,” said UK Department of Health Community and Social Care State Minister Alistair Burt. “Our long-standing ties with the UAE will continue to strengthen with the presence of King's College Hospital and Clinics in Dubai, combined with the specialist emerging markets investment management experience of Ashmore Group.”
“The UAE has a relationship with King's College Hospital that stretches back more than 30 years, since the nation’s founder, Sheikh Zayed Al Nahyan, provided a donation that helped to set up the hospital’s specialist liver research center,” commented Humaid Al Qutami, director general of the Dubai Health Authority (DHA; UAE).
Related Links:
King’s College Hospital
Ashmore Group
Al Tayer Group
The multi-specialty Kings College Hospital Dubai (UAE), scheduled to open in 2018, will offer acute and general medical services in pediatrics, endocrinology, orthopedics, and obstetrics and gynecology disciplines. The project, budgeted at USD 200 million, will be fully integrated with King's College Hospital's facilities in London (United Kingdom). King's College Hospital already operates the Abu Dhabi clinic in the UAE, which was launched in 2014.
The Ashmore Group (London, United Kingdom), a specialist emerging markets firm with over twenty years' experience will act as the investment manager, while the Al Tayer Group (Dubai, UAE) and Dubai Investments (Dubai, UAE) will act as local equity partners. Dubai Investments has taken a 26.75% stake in the new venture, but the size of stake held by King’s College Hospital or by Al Tayer Group was not disclosed.
The new hospital will contain up to 100 beds, and is due to be built at Dubai Hills within Mohammed bin Rashid City. In addition, between three and four King’s College Hospital clinics will be opened on prime sites across Dubai during 2016-2017, with between 10 and 20 doctors on site, depending on location. In all, the partnership will be seeking to recruit up to 700 staff. A significant proportion of experienced clinicians from the UK will be brought over to the hospital in Dubai, and King’s College Hospital said that all staff and services will follow its London delivery model.
“The UK public and private healthcare system is considered among the top in the world. We are extremely excited to expand British healthcare internationally, particularly within the UAE,” said UK Department of Health Community and Social Care State Minister Alistair Burt. “Our long-standing ties with the UAE will continue to strengthen with the presence of King's College Hospital and Clinics in Dubai, combined with the specialist emerging markets investment management experience of Ashmore Group.”
“The UAE has a relationship with King's College Hospital that stretches back more than 30 years, since the nation’s founder, Sheikh Zayed Al Nahyan, provided a donation that helped to set up the hospital’s specialist liver research center,” commented Humaid Al Qutami, director general of the Dubai Health Authority (DHA; UAE).
Related Links:
King’s College Hospital
Ashmore Group
Al Tayer Group
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Orthopedics Centre of Excellence Planned for Guy’s Hospital
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Columbia China to Build New Hospital in Jiaxing
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- Hospital Antibiotic Policies Improve Prescription Practices
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







